MetaCap

Bicara Therapeutics Statistics

NASDAQ: BCAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.44-0.68 (-7.46%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Bicara Therapeutics by the numbers

Bicara Therapeutics has a market capitalization of $560.3 million based on 66.39M shares outstanding. With trailing EPS of $-3.46, Bicara Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 45.3% below its 50-day average and 59.1% below its 200-day average.

Average daily trading volume is 1.20M shares, or about $10.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BCAX valuation vs. peer median

BCAX compared with the median of 8 peer companies
MetricBCAXPeer medianDifference
Market cap$560.31M$548.11M+2%
Avg. volume1.20M1.37M-12%

Peer median across 8 companies: GERN, ANL, ACRS, AVBP, CBIO, DSGN, CLYM, IMMX.

Valuation

Price and trading

Previous close
9.12
Open
8.83
Day range
8.43 – 9.14
52-week range
7.87 – 30.99
52-week change
-53.22%
Beta
—
Volume
814.49K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
560.31M
Forward Pe
-2.15
Eps
-3.46
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
30.99
Week52 Low
7.87
Avg Volume
1.20M
Shares Outstanding
66.39M
Ma50
15.43
Ma200
20.65
Earnings Date
Nov 9, 2026
Pct From52w High
-72.77%
Pct From52w Low
7.24%

Related